Novartis Institutes for Biomedical Research
Dr. Peter Hoffmann is affiliated to Preclinical Safety, Novartis Institutes for Biomedical Research. Dr. Peter Hoffmann is currently providing services as Professor. Dr. Peter Hoffmann has authored and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. Peter Hoffmann contributions have acclaimed recognition from honourable subject experts around the world. Dr. Peter Hoffmann is actively associated with different societies and academies. Dr. Peter Hoffmann academic career is decorated with several reputed awards and funding. Dr. Peter Hoffmann research interests include Preclinical Safety.
Evaluation of relative MS response factors of drug metabolites for semi-quantitative assessment of chemical liabilities in drug discovery.